Brief: Cerenis Therapeutics Holding Confirms No New Information About CER-001 Phase III Study

Abionyx Pharma SA

21/11/2018 07:09

Nov 21 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * MANAGEMENT CONFIRMS NO NEW INFORMATION RELATED TO CLINICAL
DEVELOPMENTS OF TANGO PHASE III STUDY WITH CER-001 HAS OCCURRED
    * SOLID CASH POSITION OF EUR 12.9 MILLION AT 30 SEPTEMBER
2018

Source text for Eikon:  ID:nBw9PZ8sNa 
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))